After obtaining approval from the institutional ethics committee, this prospective interventional single-blinded randomized controlled trial was registered with the Clinical Trial Registry of India. The study was conducted on 36 American Society of Anesthesiologists (ASA) I-II female patients between 18–65 years who underwent post-chemotherapy unilateral modified radical mastectomy with complete axillary clearance. The exclusion criteria were patient refusal and patient unable to give valid consent, patient undergoing supraclavicular lymph node dissection, pregnant patients, known hypersensitivity to local anesthetics, infection at the site of injection, and history of chronic analgesic use. After obtaining written informed consent, the patients were recruited between the time periods from 24th March 2023 to 30th May 2023. The study complied with the principles of the Helsinki Declaration 2013 and good clinical practices were followed.
Consenting patients were randomized into two groups with the help of a computer-generated randomization chart - the block group (Group B) and the control group (Group C). Baseline vitals were noted in the preoperative holding area.
A similar anesthesia protocol was followed for each patient. Inside the operating room after securing the intravenous access standard ASA monitors were attached. General anesthesia was induced using fentanyl 2 µg/kg, propofol 2 mg/kg, and atracurium 0.5 mg/kg intravenously (IV). The airway was secured using I-gel™ (Intersurgical Ltd, Wokingham, UK). Post-induction all patients received Dexamethasone 6 mg IV. Anaesthesia was maintained using sevoflurane, 50% nitrous oxide in oxygen, and 0.1 mg/kg boluses of atracurium. Patients were ventilated to maintain normocapnia. The minimum alveolar concentration (MAC) was maintained within the range of 0.8–1.3 to ensure adequate depth of anesthesia. Intraoperative vitals and MAC were noted at 3 min intervals. Intravenous fentanyl 0.5 µg/kg was administered if systolic blood pressure and heart rate increased to ≥ 20% of the basal values.
For patients enrolled in Group B, the blocks were provided after induction of general anesthesia. The patient’s position was supine with the arm abducted at 90°. After skin preparation with 2.5% chlorhexidine in alcohol, to identify the targeted planes, a high-frequency (6–11 MHz) linear array ultrasound transducer (M7 PremiumTM, Mindray) was used. For PECS I, the transducer was placed medial to the coracoid process in a parasagittal orientation. In the deltopectoral groove, the axillary vessels were identified above the second rib. The probe was further moved inferiorly and laterally until the third rib was encountered. The fascial plane between the pectoralis major and pectoralis minor was identified at the level of the third rib. A 20G echogenic needle was inserted from the cephalad end to reach the fascial plane. After negative aspiration, 10 ml of 0.25% bupivacaine was administered. For SAP block transducer was placed on the midaxillary line at the nipple level. The fifth and sixth ribs were identified with the pleura sliding underneath. The serratus anterior muscle lies immediately over the ribs. The needle was inserted from the anterior aspect towards the posterior direction. After negative aspiration, 25 ml of 0.25% bupivacaine was injected deep to the serratus anterior muscle.
Patients in group C did not receive any block and received only intravenous analgesics.
All patients received paracetamol 1gm and tramadol 100 mg IV prior to surgical incision. Prior to reversal, all patients received ondansetron 6 mg IV. Once the procedure was over patients were shifted to the recovery room where the NRS scores were noted at 0, 30, 60, 90, and 120 min. Any analgesic requirement (in the form of intravenous diclofenac sodium 75 mg IV or fentanyl 0.5 µg/kg bolus) during this time period and incidence of PONV were noted. Metoclopramide 10 mg IV was administered if found necessary. Patients were shifted to the ward after 2 h with a routine analgesic prescription.
The sample size was calculated using the online sample size calculator of OpenEpi (Open Source Epidemiologic Statistics for Public Health). [13] In a similar study conducted by Wang W et al. [14] it has been found that in patients who were administered a combination of PECS I and SAP block, intraoperative IV morphine equivalent consumption (mg) was significantly lower than the patients who did not receive any block [(mean ± SD) 18.10 ± 4.76 and 21.22 ± 4.17 respectively]. Morphine equivalents are optimal for opioid utilization studies as they facilitate both interpretation and comparison between opioids across geographical locations. Morphine equivalent is expressed as milligrams of morphine and is used to standardize the opioid dosage across different drugs and studies. [15] Hence we utilized the difference in morphine equivalents reported by the study for our sample size calculation. [14]
All analyses were done using R Statistical Software version 4.3.0 (2023-04-21). To test the normal distribution of the continuous data the Shapiro–Wilk test was used. Comparison between the two groups was done using the Wilcoxon rank-sum test (non-normally distributed continuous data and ordinal data) or a two-tailed Student's t-test (normally distributed continuous data). The Chi-square test was used to assess the categorical data. A P value of < 0.05 was considered statistically significant for all comparisons between the groups.